Morgan Stanley Pathway Small-Mid Cap Equity ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.62
資產淨值: 58.15
成立日期: 18/11/1991
 
分析
市值分佈:
80.57%
大市值
11.79%
中市值
3.91%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:44) 總持有投資項目: 1806  
0%
 
100%
     10大 (6.11%)
代號 名稱 佔比% ▼ 持有日期
HURNHuron Consulting Group0.0231/10/2026
FFBCFirst Financial Bancorp0.0231/10/2026
POWIPower Integrations0.0231/10/2026
CLMTCalumet Inc.0.0231/10/2026
DRSLeonardo DRS0.0231/10/2026
USPHUS Physical Therapy0.0231/10/2026
RKLBRocket Lab Corporation0.0231/10/2026
NHINational Health Investors0.0231/10/2026
BOKFBOK Financial Corp0.0231/10/2026
CLOVClover Health Investments Corp0.0231/10/2026
CLDXCelldex Therapeutics0.0231/10/2026
CHHChoice Hotels Intnl0.0231/10/2026
FHBFirst Hawaiian0.0231/10/2026
EFCEllington Financial0.0231/10/2026
BIPCBrookfield Infrastructure Corporation Brookfield Infrastructure Corporation0.0231/10/2026
NWSNews Corp0.0231/10/2026
SKYWSkyWest0.0231/10/2026
KAIKadant0.0231/10/2026
TMDXTransMedics Group0.0231/10/2026
OSWOneSpaWorld Holdings Limited0.0231/10/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16    17    18    19    20    21    22    23    24    25    26    27    28    29    30    31    32    33    34    35    36    37    38    39    40    41    42    43    44    45    46   47    48    49    50    51    52    53    54    55    56    57    58    59    60    61    62    63    64    65    66    67    68    69    70    71    72    73    74    75    76    77    78    79    80    81    82    83    84    85    86    87    88    89    90    91  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.